Literature DB >> 2664520

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

J Eriksson1, A Franssila-Kallunki, A Ekstrand, C Saloranta, E Widén, C Schalin, L Groop.   

Abstract

To identify early metabolic abnormalities in non-insulin-dependent diabetes mellitus (NIDDM), we measured sensitivity to insulin and insulin secretion in 26 first-degree relatives of patients with NIDDM and compared these subjects both with 14 healthy control subjects with no family history of NIDDM and with 19 patients with NIDDM. The euglycemic insulin-clamp technique, indirect calorimetry, and infusion of [3-3H]glucose were used to assess insulin sensitivity. Total-body glucose metabolism was impaired in the first-degree relatives as compared with the controls (P less than 0.01). The defect in glucose metabolism was almost completely accounted for by a defect in nonoxidative glucose metabolism (primarily the storage of glucose as glycogen). The relatives with normal rates of metabolism (mean +/- SEM, 1.81 +/- 0.27 mg per kilogram of body weight per minute) and impaired rates (1.40 +/- 0.22 mg per kilogram per minute) in oral glucose-tolerance tests had the same degree of impairment in glucose storage as compared with healthy control subjects (3.76 +/- 0.55 mg per kilogram per minute; P less than 0.01 for both comparisons). During hyperglycemic clamping, first-phase insulin secretion was lacking in patients with NIDDM (P less than 0.01) and severely impaired in their relatives with impaired glucose tolerance (P less than 0.05) as compared with control subjects; insulin secretion was normal in the relatives with normal glucose tolerance. We conclude that impaired glucose metabolism is common in the first-degree relatives of patients with NIDDM, despite their normal results on oral glucose-tolerance tests. Both insulin resistance and impaired insulin secretion are necessary for the development of impaired glucose tolerance in these subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664520     DOI: 10.1056/NEJM198908103210601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  178 in total

1.  Pathogenesis of insulin resistance in type 2 diabetes: a collision between thrifty genes and an affluent environment.

Authors:  L C Groop
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 2.  Strategies and prospects for finding insulin resistance genes.

Authors:  M P Stern
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.

Authors:  A J Krentz; C J Bailey; A Melander
Journal:  BMJ       Date:  2000-07-29

Review 4.  Genetic determinants of diabetes and atherosclerosis.

Authors:  Braxton D Mitchell; Ikhide G Imumorin
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

5.  A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study.

Authors:  B Isomaa; B Forsén; K Lahti; N Holmström; J Wadén; O Matintupa; P Almgren; J G Eriksson; V Lyssenko; M-R Taskinen; T Tuomi; L C Groop
Journal:  Diabetologia       Date:  2010-05-08       Impact factor: 10.122

6.  Skeletal muscle insulin resistance: is it important for the pathogenesis of type 2 diabetes after all?

Authors:  H A Koistinen; J R Zierath
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 7.  Gene expression in the pathophysiology of type 2 diabetes mellitus.

Authors:  Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 8.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  A large sample of finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter.

Authors:  S Ghosh; E R Hauser; V L Magnuson; T Valle; D S Ally; Z E Karanjawala; J B Rayman; J I Knapp; A Musick; J Tannenbaum; C Te; W Eldridge; S Shapiro; T Musick; C Martin; A So; A Witt; J B Harvan; R M Watanabe; W Hagopian; J Eriksson; S J Nylund; K Kohtamaki; E Tuomilehto-Wolf; M Boehnke
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes.

Authors:  L Mosthaf; J Eriksson; H U Häring; L Groop; E Widen; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.